Ultrasis (LSE:ULT) ROCE %: -80.63% (As of Jul. 2014)


What is Ultrasis ROCE %?

Ultrasis LSE:ULT ROCE % is -80.63% as of Jul. 2014. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ultrasis's annualized ROCE % for the quarter that ended in Jul. 2014 was -80.63%.


Ultrasis  (LSE:ULT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Ultrasis ROCE % Related Terms


Ultrasis ROCE % Historical Data

* Premium members only.

The historical data trend for Ultrasis's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ultrasis ROCE % Chart

Ultrasis Annual Data
Trend Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.76 0.33 -27.93 -119.78 -80.63

Ultrasis Semi-Annual Data
Jul96 Jul97 Jul98 Jul99 Jul00 Jul01 Jul02 Jul03 Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.76 0.33 -27.93 -119.78 -80.63

Ultrasis ROCE % Calculation

Ultrasis's annualized ROCE % for the fiscal year that ended in Jul. 2014 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jul. 2014 )  (A: Jul. 2013 )(A: Jul. 2014 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jul. 2014 )  (A: Jul. 2013 )(A: Jul. 2014 )
=-1.428/( ( (1.611 - 0.516) + (3.743 - 1.296) )/ 2 )
=-1.428/( (1.095+2.447)/ 2 )
=-1.428/1.771
=-80.63 %

Ultrasis's ROCE % of for the quarter that ended in Jul. 2014 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jul. 2014 )  (Q: Jul. 2013 )(Q: Jul. 2014 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jul. 2014 )  (Q: Jul. 2013 )(Q: Jul. 2014 )
=-1.428/( ( (1.611 - 0.516) + (3.743 - 1.296) )/ 2 )
=-1.428/( ( 1.095 + 2.447 )/ 2 )
=-1.428/1.771
=-80.63 %

(1) Note: The EBIT data used here is one times the annual (Jul. 2014) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -80.63% mean?
Ultrasis (LSE:ULT) has a ROCE % of -80.63% as of Jul. 2014.
Is Ultrasis' ROCE % too high?
Ultrasis' current ROCE % is -80.63%.
How does Ultrasis' ROCE % compare to competitors?
Ultrasis' ROCE % of -80.63% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ultrasis's current ROCE % is -80.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultrasis stock overvalued right now?
Ultrasis (LSE:ULT) has a current ROCE % of -80.63%. The current ROCE % is -80.63%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ultrasis (LSE:ULT), the current ROCE % is -80.63% as of Jul. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ultrasis Business Description

Ultrasis PLC was incorporated in November 23, 1981. The Company through its subsidiary provides healthcare products and services provided via the medium of technology or face to face, that help people maintain, regain and improve their physical, psychological and social well-being. Its product includes Beating the Blues(r), GetFit Wellness, My Brain Solutions, The Relief Series, Drink & Drug Wise, Calm Workplace, and Optimise Me, Screenetics and Joggle.